ClinicalTrials.Veeva

Menu

Af Ablation In Brady-Tachy Syndrome (Alternative)

Abbott logo

Abbott

Status

Terminated

Conditions

Brady-tachy Syndrome

Treatments

Procedure: AF ablation + pacemaker implantation
Procedure: Pacemaker implantation

Study type

Interventional

Funder types

Industry

Identifiers

NCT00740272
SJM-FR01

Details and patient eligibility

About

The aim of the study is to evaluate the impact of atrial fibrillation ablation in patients presenting a brady-tachy syndrome on the AF burden.

The hypothesis of the study is that AF ablation prevents not only from AF episodes recurrence but also from bradycardic episodes.

Full description

The study is a randomized study 1:1 AF ablation vs non AF ablation. Patients are followed for 1 year. 38 patients will be required to show a significant reduction in AF burden.

Enrollment

38 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • paroxystic AF
  • symptomatic pauses (>5s at night or 3s during daytime)

Exclusion criteria

  • permanent AF
  • age > 80 y
  • pregnant women
  • minors

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

38 participants in 2 patient groups

1
Experimental group
Description:
AF ablation + pacemaker
Treatment:
Procedure: AF ablation + pacemaker implantation
2
Active Comparator group
Description:
Pacemaker
Treatment:
Procedure: Pacemaker implantation

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems